Obalon Therapeutics Inc - CA San Diego, Carlsbad 92008

Obalon Therapeutics Inc entered the industry of Commercial Photo Laboratories in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 812921, which describes it as a Commercial Photo Laboratories. For further clarification, the SIC classifies this business under the code 7384 and described it as a Commercial Photo Laboratories. The business provides service to the B2B market.

To acquire more information, please contact Andrew P Rasdal by calling (760) 607-5151 during business hours. You can also write to the business’ Headquarters at 5421 Avd Encinas # F, Carlsbad, California CA 92008. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Obalon Therapeutics Inc
Representative: Andrew P Rasdal
Place of Business: 5421 Avd Encinas # F, Carlsbad, CA 92008
Contact Number: (760) 607-5151
Type of Service: Commercial Photo Laboratories
SIC Number: 7384
NAICS Number: 812921
Locality: Headquarters
Market Type: B2B (Business to Business)
Began: 2008
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Obalon Therapeutics Inc is a company operating from San Diego, California providing professional Commercial Photo Laboratories and relevant B2B variables. It was founded in 2008 and registered with the SIC code 7384 as Commercial Photo Laboratories, and with the NAICS code 812921 as Commercial Photo Laboratories.

With a current employee count of 1 to 4, Obalon Therapeutics Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Andrew P Rasdal at (760) 607-5151 for related queries, or to locate its Headquarters using the coordinates 33.128473,-117.326537.

The Headquarters can also be found at the street address 5421 Avd Encinas # F in Carlsbad, California 92008 and can be engaged online through the company website at , the company Twitter , and Facebook page .